The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required

International Journal of Oncology

Volumn 50, Issue 6, 2017, Pages 1989-1999

  Zhao, Kai ^a   Leilei, Wang ^b   Li, Tao ^a   Zhu, Meng ^c   Chen, Zhang ^a   Chen, Lei ^a   Zhao, Pengfei ^a   Zhou, Hua ^a   Yu, Shengping ^a   Yang, Xuejun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CANGZHOU CENTRAL HOSPITAL   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

AMPK; Cofilin; Glioma; Migration; MiR 451; MTORC1; Rac1

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM BINDING PROTEIN 39; COFILIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 451; RAC1 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; COFILIN 1; MIRN451 MICRORNA, HUMAN; MO25 PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; PRKAA1 PROTEIN, HUMAN; RAC1 PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; BRAIN TISSUE; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLOGY; ENZYME ACTIVITY; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; UPREGULATION; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

AMP-ACTIVATED PROTEIN KINASES; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COFILIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR MICROENVIRONMENT;

EID: 85019632184     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2017.3973     Document Type: Article

References (39)

1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al: Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007
2. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG and Parada LF: A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488: 522-526, 2012
3. Westermark B: Glioblastoma: a moving target. Ups J Med Sci 117: 251-256, 2012
4. Giese A, Bjerkvig R, Berens ME and Westphal M: Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636, 2003
5. Wild-Bode C, Weller M, Rimner A, Dichgans J and Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750, 2001
6. Di Nicolantonio F, Mercer SJ, Knight LA, Gabriel FG, Whitehouse PA, Sharma S, Fernando A, Glaysher S, Di Palma S, Johnson P, et al: Cancer cell adaptation to chemotherapy. BMC Cancer 5: 78, 2005
7. Wu Y and Zhou BP: New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 40: 643-650, 2008
8. Hatzikirou H, Basanta D, Simon M, Schaller K and Deutsch A: 'Go or grow': the key to the emergence of invasion in tumour progression? Math Med Biol 29: 49-65, 2012
9. Wullschleger S, Loewith R and Hall MN: TOR signaling in growth and metabolism. Cell 124: 471-484, 2006
10. Liu X, Zhang X, Xiang J, Lv Y and Shi J: miR-451: Potential role as tumor suppressor of human hepatoma cell growth and invasion. Int J Oncol 45: 739-745, 2014
11. Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y, Yue X, Pu P, Zhong Y and Kang C: MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 1359: 14-21, 2010
12. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004
13. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27: 91-105, 2007
14. Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009
15. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006
16. Hatziapostolou M and Iliopoulos D: Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 68: 1681-1702, 2011
17. Iorio MV and Croce CM: microRNA involvement in human cancer. Carcinogenesis 33: 1126-1133, 2012
18. Zhang Y, Dutta A and Abounader R: The role of microRNAs in glioma initiation and progression. Front Biosci (Landmark Ed) 17: 700-712, 2012
19. Gits CM, van Kuijk PF, Jonkers MB, Boersma AW, Smid M, van Ijcken WF, Coindre JM, Chibon F, Verhoef C, Mathijssen RH, et al: MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors. Int J Cancer 135: 348-361, 2014
20. Liu D, Liu C, Wang X, Ingvarsson S and Chen H: MicroRNA-451 suppresses tumor cell growth by down-regulating IL6R gene expression. Cancer Epidemiol 38: 85-92, 2014
21. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, Van Brocklyn J, Ostrowski MC, Chiocca EA and Lawler SE: MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 37: 620-632, 2010
22. Azab AK, Azab F, Blotta S, Pitsillides CM, Thompson B, Runnels JM, Roccaro AM, Ngo HT, Melhem MR, Sacco A, et al: RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma. Blood 114: 619-629, 2009
23. Giese A, Loo MA, Tran N, Haskett D, Coons SW and Berens ME: Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67: 275-282, 1996
24. Tamaki M, McDonald W, Amberger VR, Moore E and Maestro RF: Implantation of C6 astrocytoma spheroid into collagen type I gels: Invasive, proliferative, and enzymatic characterizations. J Neurosurg 87: 602-609, 1997
25. Yu SP, Yang XJ, Zhang B, Ming HL, Chen C, Ren BC, Liu ZF and Liu B: Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells. Chin Med J (Engl) 124: 2599-2604, 2011
26. de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y and Conrad CA: Tumor invasion after treatment of glioblastoma with bevacizumab: Radiographic and pathologic correlation in humans and mice. Neuro oncol 12: 233-242, 2010
27. Hardie DG: AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8: 774-785, 2007
28. Hardie DG and Carling D: The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997
29. Hardie DG, Scott JW, Pan DA and Hudson ER: Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120, 2003
30. Carling D: The AMP-activated protein kinase cascade-A unifying system for energy control. Trends Biochem Sci 29: 18-24, 2004
31. Hardie DG: The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117: 5479-5487, 2004
32. Kahn BB, Alquier T, Carling D and Hardie DG: AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25, 2005
33. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG and Hardie DG: Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2: 9-19, 2005
34. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR and Witters LA: The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280: 29060-29066, 2005
35. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M and Carling D: Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2: 21-33, 2005
36. Fan QW, Cheng C, Knight ZA, Haas-Kogan D, Stokoe D, James CD, McCormick F, Shokat KM and Weiss WA: EGFR signals to mTOR through PKC and independently of Akt in glioma. Sci Signal 2: ra4, 2009
37. Horwitz AR and Parsons JT: Cell migration: 'movin' on. Science 286: 1102-1103, 1999
38. Forget MA, Desrosiers RR, Gingras D and Béliveau R: Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J 361: 243-254, 2002
39. Zhang B, Sun J, Yu SP, Chen C, Liu B, Liu ZF, Ren BC, Ming HL and Yang XJ: Rac1 cells distributed in accordance with CD 133 cells in glioblastomas and the elevated invasiveness of CD 133 glioma cells with higher Rac1 activity. Chin Med J 125: 4344-4348, 2012